People

Deena Altman
Deena R. Altman, MD, MSc
Icahn School of Medicine at Mount Sinai - Associate Professor, Department of Medicine, Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai - Associate Professor, Genetics and Genomic Sciences
Education
MD, Medical School for International Health at Ben Gurion University
MSc, Clinical Research, Icahn School of Medicine at Mount Sinai
BS, Psychobiology, Binghamton University
Research Interests
Staphylococcus aureus, bacterial genomics, molecular epidemiology, hospital and community associated infections, microbial drug resistance
BIO
Deena Altman is an Internal Medicine physician, sub-specializing in Infectious Diseases (ID). She completed a 3-year fellowship in ID in addition to a Master of Clinical Research at the Icahn School of Medicine at Mount Sinai. Her research focus is on patient-oriented studies of Staphylococcus aureus (S. aureus) pathogenesis, epidemiology, and genomics. She investigates the capabilities of genomics to delineate both intra- and inter-host adaptation. She is the initiator of the collaborative Pathogen Surveillance Program (PSP) which uses genomics to define pathogen diversity at the Mount Sinai Health System. Her clinical responsibilities include inpatient ID consultations, inpatient clinical trials, and outpatient HIV primary care services.
Publications

Recent

Yates JL, Hunt DT, Kulas KE, Chave KJ, Styer L, Chakravarthi ST, Cai GY, Bermudez-Gonzalez MC, Kleiner G, Altman D, Srivastava K, Simon V, Feihel D, McGowan J, Hogrefe W, Noone P, Egan C, Slifka MK, Lee WT (2023).
Development of a novel serological assay for the detection of mpox infection in vaccinated populations
Journal of Medical Virology, 95 (10), e29134. doi: 10.1002/jmv.29134. PMCID: PMC10686281.

Dyzenhaus S, Sullivan MJ, Alburquerque B, Boff D, van de Guchte A, Chung M, Fulmer Y, Copin R, Ilmain JK, O'Keefe A, Altman DR, Stubbe FX, Podkowik M, Dupper AC, Shopsin B, van Bakel H, Torres VJ (2023).
MRSA lineage USA300 isolated from bloodstream infections exhibit altered virulence regulation
Cell Host and Microbe, 31 (2), 228-242.e8. doi: 10.1016/j.chom.2022.12.003. PMCID: PMC9911362.

Reategui Schwarz E, van de Guchte A, Dupper AC, Berbel Caban A, Nadkarni D, Fox L, Mills A, Obla A, Chacko KI, Oussenko I, Samaroo F, Polanco J, Silvera R, Smith ML, Patel G, Gitman M, Alburquerque B, Chung M, Sullivan MJ, van Bakel H, Altman DR (2022).
Everybody nose: Molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection
BMC Infectious Diseases, 22 (1), 400. doi: 10.1186/s12879-022-07371-w. PMCID: PMC9036699.

Berbel Caban A, Pak TR, Obla A, Dupper AC, Chacko KI, Fox L, Mills A, Ciferri B, Oussenko I, Beckford C, Chung M, Sebra R, Smith M, Conolly S, Patel G, Kasarskis A, Sullivan MJ, Altman DR, van Bakel H (2020).
PathoSPOT genomic epidemiology reveals under-the-radar nosocomial outbreaks
Genome Medicine, 12 (1), 96. doi: 10.1186/s13073-020-00798-3. PMCID: PMC7670629.

Dupper AC, Sullivan MJ, Chacko KI, Mishkin A, Ciferri B, Kumaresh A, Berbel Caban A, Oussenko I, Beckford C, Zeitouni NE, Sebra R, Hamula C, Smith M, Kasarskis A, Patel G, McBride RB, van Bakel H, Altman DR (2019).
Blurred molecular epidemiological lines between the two dominant methicillin-resistant Staphylococcus aureus clones
Open Forum Infectious Diseases, 6 (9), ofz302. doi: 10.1093/ofid/ofz302. PMCID: PMC6735859.

Dr. Altman's MyBibliography Profile